scholarly article | Q13442814 |
P356 | DOI | 10.1016/J.VACCINE.2012.02.071 |
P698 | PubMed publication ID | 22406460 |
P50 | author | Gary P. Kobinger | Q66679700 |
Kate E. Broderick | Q87200293 | ||
Alexander Bello | Q123019198 | ||
P2093 | author name string | Niranjan Y Sardesai | |
Feng Lin | |||
Jonas Söderholm | |||
Xuefei Shen | |||
Derek A Gregg | |||
P2860 | cites work | Increased immune response elicited by DNA vaccination with a synthetic gp120 sequence with optimized codon usage | Q24531468 |
A history of influenza | Q28189170 | ||
A constant rate of spontaneous mutation in DNA-based microbes | Q28271032 | ||
Influenza: evolving strategies in treatment and prevention | Q28299371 | ||
The annual impact of seasonal influenza in the US: Measuring disease burden and costs | Q29030744 | ||
Immunogenicity of novel consensus-based DNA vaccines against avian influenza. | Q30359911 | ||
Influenza viruses and the evolution of avian influenza virus H5N1. | Q30364962 | ||
Bench-to-bedside review: vaccine protection strategies during pandemic flu outbreaks | Q30389582 | ||
Prototype development and preclinical immunogenicity analysis of a novel minimally invasive electroporation device. | Q30395101 | ||
Heterosubtypic protection against pathogenic human and avian influenza viruses via in vivo electroporation of synthetic consensus DNA antigens | Q33346277 | ||
Multiple effects of codon usage optimization on expression and immunogenicity of DNA candidate vaccines encoding the human immunodeficiency virus type 1 Gag protein | Q33849127 | ||
Increased DNA vaccine delivery and immunogenicity by electroporation in vivo | Q33899313 | ||
Research and development of universal influenza vaccines | Q34093195 | ||
Novel engineered HIV-1 East African Clade-A gp160 plasmid construct induces strong humoral and cell-mediated immune responses in vivo | Q34265962 | ||
High-efficiency gene transfer into skeletal muscle mediated by electric pulses | Q35123357 | ||
Biochemistry of human skin--our brain on the outside | Q36347435 | ||
Novel linear DNA vaccines induce protective immune responses against lethal infection with influenza virus type A/H5N1. | Q37001633 | ||
Electroporation of synthetic DNA antigens offers protection in nonhuman primates challenged with highly pathogenic avian influenza virus | Q37157152 | ||
Dendritic cells: biology of the skin | Q37363179 | ||
Electroporation: a promising method for the nonviral delivery of DNA vaccines in humans? | Q37823343 | ||
Intradermal influenza vaccine and new devices: a promising chance for vaccine improvement | Q37836900 | ||
Electroporation delivery of DNA vaccines: prospects for success | Q37870313 | ||
Recruitment of antigen-presenting cells to the site of inoculation and augmentation of human immunodeficiency virus type 1 DNA vaccine immunogenicity by in vivo electroporation | Q38610641 | ||
Vaccination with polymerase chain reaction-generated linear expression cassettes protects mice against lethal influenza A challenge | Q40092310 | ||
DNA supercoiling: Another level for regulating gene expression | Q40125224 | ||
Transformation ofEscherichia coliwith large DNA molecules by electroporation | Q40394313 | ||
Induction of potent Th1-type immune responses from a novel DNA vaccine for West Nile virus New York isolate (WNV-NY1999). | Q40596844 | ||
Study of mechanisms of electric field-induced DNA transfection. V. Effects of DNA topology on surface binding, cell uptake, expression, and integration into host chromosomes of DNA in the mammalian cell | Q41861128 | ||
Electropermeabilization of skeletal muscle enhances gene transfer in vivo | Q45862087 | ||
Spatial-temporal patterns of gene expression in mouse skeletal muscle after injection of lacZ plasmid DNA. | Q45883348 | ||
A comprehensive study of optimal conditions for naked plasmid DNA transfer into skeletal muscle by electroporation | Q45883425 | ||
A novel prototype device for electroporation-enhanced DNA vaccine delivery simultaneously to both skin and muscle. | Q46593022 | ||
Increased gene expression and inflammatory cell infiltration caused by electroporation are both important for improving the efficacy of DNA vaccines | Q47727853 | ||
Expression of transfected DNA depends on DNA topology | Q68727592 | ||
Intradermal/subcutaneous immunization by electroporation improves plasmid vaccine delivery and potency in pigs and rhesus macaques | Q80204825 | ||
Factors influencing the efficacy, longevity, and safety of electroporation-assisted plasmid-based gene transfer into mouse muscles | Q80507043 | ||
P433 | issue | 48 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | electroporation | Q1142521 |
P304 | page(s) | 6946-6954 | |
P577 | publication date | 2012-03-08 | |
P1433 | published in | Vaccine | Q7907941 |
P1476 | title | Influenza A vaccines using linear expression cassettes delivered via electroporation afford full protection against challenge in a mouse model | |
P478 | volume | 30 |
Q33723334 | A multi-head intradermal electroporation device allows for tailored and increased dose DNA vaccine delivery to the skin |
Q53272516 | A multi-head intradermal electroporation device allows for tailored and increased dose DNA vaccine delivery to the skin. |
Q30427950 | Antibody-dependent cellular cytotoxicity is associated with control of pandemic H1N1 influenza virus infection of macaques |
Q92428731 | Archaeal glycolipid adjuvanted vaccines induce strong influenza-specific immune responses through direct immunization in young and aged mice or through passive maternal immunization |
Q38791353 | Cytomegalovirus Vaccines: Current Status and Future Prospects. |
Q38670879 | DNA-based influenza vaccines as immunoprophylactic agents toward universality |
Q38081775 | Daedalic DNA vaccination against self antigens as a treatment for chronic kidney disease. |
Q59349904 | Efforts to Improve the Seasonal Influenza Vaccine |
Q37530445 | Electroporation mediated DNA vaccination directly to a mucosal surface results in improved immune responses |
Q38285418 | Electroporation-enhanced delivery of nucleic acid vaccines |
Q35680631 | Expression and Characterization of the RKOD DNA Polymerase in Pichia pastoris |
Q34291098 | Fast vaccine design and development based on correlates of protection (COPs). |
Q33880398 | Humoral and Cellular Immunogenicity Induced by Avian Influenza A (H7N9) DNA Vaccine in Mice |
Q30380290 | Induction of Broad-Based Immunity and Protective Efficacy by Self-amplifying mRNA Vaccines Encoding Influenza Virus Hemagglutinin |
Q33586294 | Optimization of electroporation-enhanced intradermal delivery of DNA vaccine using a minimally invasive surface device |
Q38647070 | Recent outbreaks of highly pathogenic avian influenza viruses in South Korea. |
Q36069582 | Synthetic DNA approach to cytomegalovirus vaccine/immune therapy |
Q37035833 | Traditional and new influenza vaccines |
Search more.